Information about De Ruyck Pharma
My details
*
*
*

De Ruyck Pharma (SRL)

Company information

Status
Active

Enterprise number

BE0818.535.488

VAT liability
Yes
Established
07-09-2009
Last balance sheet year
2025
Company size
Small 0,2 FTE
Principal activity
Retail sale of pharmaceutical products
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from De Ruyck Pharma

2025 2024 2023 2022
Profit/Loss 48,219 -4 % 50,055 -9 % 55,070 9 % 50,470
Equity 306,908 2 % 300,199 20 % 250,144 3 % 243,708
Gross margin 199,257 12 % 178,233 -29 % 249,852 0 % 249,072
Employees 0.2 0.8 1

Publications from De Ruyck Pharma

Date Publication
26-01-2024 Modification(s) Articles of Association (NL)
27-02-2015 Resignations - Appointments (NL)
26-07-2013 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (NL)
14-06-2012 Resignations - Appointments (NL)
08-10-2010 Registered Office (NL)

Frequently asked questions

What is the VAT number of De Ruyck Pharma?
The VAT number of De Ruyck Pharma is BE 0818.535.488.
Wat is the PEPPOL ID of De Ruyck Pharma?
The PEPPOL ID of De Ruyck Pharma is 0208:0818535488. Log in or start a free trial to see the full overview.
When was De Ruyck Pharma founded?
De Ruyck Pharma was founded on 07-09-2009.
What is the address of De Ruyck Pharma?
The current registered office of De Ruyck Pharma is located at Aarseleweg 2, 9800 Deinze.
When was the last time De Ruyck Pharma filed their annual financial statements?
The most recent financial statements of De Ruyck Pharma were filed on 29-10-2025.
How many employees does De Ruyck Pharma have?
There are 0,2 FTEs working at De Ruyck Pharma according to the staff figures in the most recent financial statements.
What is the annual turnover of De Ruyck Pharma?
At the time of its most recent financial statements, De Ruyck Pharma did not publish any turnover figures. De Ruyck Pharma reported a gross margin of €199,256.55.